rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Sitagliptin

Rediff.com  »  News  »   Sitagliptin

  News for Sitagliptin

  • Business

Sun Pharma, Merck to market diabetes drugs

Sun Pharmaceutical Industries Ltd and MSD in India said they have entered into a partnership to market diabetes drugs Sitagliptin and Sitaglipitin plus Metformin in the Indian market.Under the......

Merck & Co wins injunction against Indian firm over diabetes drugs

MSD, a unit of US drugmaker Merck & Co, said it has won an injunction against India's Aprica Pharmaceuticals and a source said this will stop Aprica launching generic versions of two diabetes drugs......

Drug patent row: HC to hear US co on Apr 12

Delhi High Court on Wednesday posted for April 12 an appeal filed by US pharmaceuticals major Merck Sharp and Dohme against the single judge bench order refusing to restrain Indian firm Glenmark......

MNCs' diabetes drug patents worry experts

Even as India is fast turning into the diabetes capital of the world, multinational drug companies are busy patenting new-generation diabetes medicines for exclusive marketing rights in the......
  Web results for Sitagliptin
Analyzing Medicare's $121 billion spend

View: 311 In less than three weeks, Donald Trump will assume office as the President of the United States. He has mentioned that he wants... ...

http://www.pharmacompass.com/radio-compass-blog/drug-costs-and-prescription-trends-in-the-united-states-analyzing-medicare-s-121-billion-spend
EU CTD Dossiers Available // Looking for Marketing Partners in the EU for various products [ENA00142]

Inventia Healthcare, one of the leading drug delivery companies in India is searching for partners in Europe for the following products which are... ...

http://www.pharmacompass.com/find-manufacturers-suppliers-distributors-services/eu-ctd-dossiers-available-looking-for-marketing-partners-in-the-eu-for-various-products-ena00142
Global Diabetes and Obesity Drugs Market to 2022 Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment

MRRS adds "Global Diabetes and Obesity Drugs Market to 2022 Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in... ...

http://pressreleaseping.com/pressrelease/220851.html
Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

MRRS adds "Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 Increasing Usage of Newer Therapies and Expanding Treatment... ...

http://pressreleaseping.com/pressrelease/220604.html
Novo Nordisk Files for Regulatory Approval of Once-Weekly Semaglutide with the FDA for the Treatment of Type 2..

Novo Nordisk A S (NYSE:NVO) Intraday Stock Chart Today : Monday 5 December 2016 PLAINSBORO, N.J. , Dec. 5, 2016 /PRNewswire/ --Novo Nordisk... ...

http://in.advfn.com/news_Novo-Nordisk-Files-for-Regulatory-Approval-of-Once_73063419.html

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages


sitagliptin
Sitagliptin


0 Followers

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z